LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0852 | Name | MAFA-AS1 | Aliases | TCONS_00014882 | |
Species | Homo sapiens | Chromosome | 8 | Start site | 143417679 | |
End site | 143419150 | Chain | plus | Exon NO. | 2 | |
Assembly | Ensembl Release 89 | Class | antisense | NCBI accession | NR_126358 | |
Ensembl | ENSG00000254338 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
lung adenocarcinoma | microarray, qPCR etc. | lung adenocarcinoma tissue | up-regulated | expression | We initially identified a number of interesting candidate lncRNAs for further analysis. Of these, LOC100132354 and RPLP0P2 exhibited the most significantly changed expression in our analysis of 100 pairs of lung adenocarcinoma and normal lung tissue samples. The expression of LOC100132354 was significantly higher in lung adenocarcinoma than in the adjacent tissues, while the expression of RPLP0P2 was significantly lower in lung adenocarcinoma than in the adjacent tissues. | 25089627 | Lnc2Cancer | ||
non-small cell lung cancer | microarray, qPCR etc. | NSCLC tissue | up-regulated | expression | we initially identified a number of significant candidate lncRNAs (including GUCY1B2, RP11-385J1.2, AC018865.8, RP11-909N17.3, GNAS-AS1, TUBA4B, Z82214.3, XLOC_000371, AC013264.2 and RP1-317E23.3) and verified the expression of these lncRNAs by RT-qPCR with GAPDH as the reference gene, by calculating the 2-CT values. | 25394782 | Lnc2Cancer | ||